KDNY - Chinook Therapeutics gains as HSR waiting period expires in Novartis deal
2023-08-01 08:51:10 ET
- Chinook Therapeutics ( NASDAQ: KDNY ) rose almost 3% in premarket trading after the Hart-Scott Rodino antitrust waiting period for its planned sale to Novartis ( NYSE: NVS ) expired.
- The HSR wating period for the sale of Chinook ( KDNY ) expired at midnight on Monday, according to a proxy filing. The Chinook shareholder vote on the deal is scheduled for Wednesday.
- The update comes after Novartis ( NVS ) agreed to acquire biopharmaceutical company, Chinook Therapeutics ( KDNY ) f or $40 per share in cash, or a total of $3.2 billion, in June.
For further details see:
Chinook Therapeutics gains as HSR waiting period expires in Novartis deal